About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Myb
myeloblastosis oncogene
MGI:97249
74 phenotypes from 11 alleles in 12 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Mybboo/Mybboo
involves: C57BL/6 		abnormal B cell differentiation J:167270
abnormal common lymphocyte progenitor cell morphology J:167270
abnormal definitive hematopoiesis J:167270
abnormal embryonic erythropoiesis J:167270
abnormal erythrocyte morphology J:167270
abnormal erythropoiesis J:167270
abnormal leukocyte morphology J:167270
abnormal megakaryocyte morphology J:167270
abnormal spleen morphology J:167270
anemia J:167270
decreased neutrophil cell number J:167270
decreased spleen white pulp amount J:167270
enlarged spleen J:167270
increased hematopoietic stem cell number J:167270
increased megakaryocyte cell number J:167270
increased nucleated erythrocyte cell number J:167270
increased number of Howell-Jolly bodies J:167270
increased spleen red pulp amount J:167270
polychromatophilia J:167270
reticulocytosis J:167270
thrombocytosis J:167270
MybM303V/MybM303V
involves: 129S1/SvlmJ * C57BL/6 		abnormal megakaryocyte differentiation J:96507
abnormal platelet shape J:96507
absent common myeloid progenitor cells J:96507
anemia J:96507
arrested B cell differentiation J:96507
arrested T cell differentiation J:96507
decreased B cell number J:96507
decreased eosinophil cell number J:96507
decreased erythrocyte cell number J:96507
decreased single-positive T cell number J:96507
decreased thymocyte number J:96507
increased bone marrow cell number J:96507
increased hematopoietic stem cell number J:96507
macrocytosis J:96507
thrombocytosis J:96507
Mybtm1.1Cgn/Myb+
involves: 129P2/OlaHsd * C57BL/6 		arrested B cell differentiation J:127234
decreased B-1 B cell number J:127234
decreased mature B cell number J:127234
decreased pre-B cell number J:127234
Mybtm1.1Cgn/Mybtm1.1Cgn
involves: 129P2/OlaHsd * C57BL/6 		anemia J:91122
lethality throughout fetal growth and development, complete penetrance J:91122
Mybtm1.1Jof/Mybtm1.1Jof
involves: 129/Sv * C57BL/6 		no abnormal phenotype detected J:85344
Mybtm1b(KOMP)Wtsi/Myb+
C57BL/6N-Mybtm1b(KOMP)Wtsi/Ucd 		hemorrhage J:211773
spina bifida J:211773
Mybtm1b(KOMP)Wtsi/Mybtm1b(KOMP)Wtsi
C57BL/6N-Mybtm1b(KOMP)Wtsi/Ucd 		abnormal skin appearance J:211773
edema J:211773
hemorrhage J:211773
pallor J:211773
preweaning lethality, incomplete penetrance J:211773
spina bifida J:211773
Mybtm1Cgn/Mybtm1.1Cgn
involves: 129P2/OlaHsd * C57BL/6 		no abnormal phenotype detected J:91122
Mybtm1Cgn/Mybtm1.1Cgn
Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 		decreased CD4-positive, alpha-beta T cell number J:91122
decreased double-positive T cell number J:91122
thymus hypoplasia J:91122
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)1Cwi/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 		arrested T cell differentiation J:91122
decreased CD4-positive, alpha-beta T cell number J:91122
decreased CD8-positive, alpha-beta T cell number J:91122
decreased double-negative T cell number J:91122
decreased double-positive T cell number J:91122
decreased gamma-delta T cell number J:91122
thymus hypoplasia J:91122
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 		decreased CD4-positive, alpha-beta T cell number J:91122
decreased double-positive T cell number J:91122
thymus hypoplasia J:91122
Mybtm1Epr/Mybtm1Epr
Tg(Cd4-cre)1Cwi/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 		abnormal T cell differentiation J:93481
decreased CD4-positive, alpha-beta T cell number J:93481
decreased double-positive T cell number J:93481
increased CD8-positive, alpha-beta T cell number J:93481
thymus hypoplasia J:93481
Mybtm1Epr/Mybtm1Epr
Tg(Lck-cre)548Jxm/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA 		abnormal double-negative T cell morphology J:93481
abnormal T cell differentiation J:93481
decreased double-positive T cell number J:93481
thymus hypoplasia J:93481
Mybtm1Jof/Mybtm1Jof
involves: 129/Sv * C57BL/6 		abnormal B cell differentiation J:85344
abnormal definitive hematopoiesis J:85344
abnormal double-negative T cell morphology J:85344
abnormal erythropoiesis J:85344
abnormal liver development J:85344
abnormal myeloblast morphology/development J:85344
abnormal T cell differentiation J:85344
decreased body size J:85344
decreased thymocyte number J:85344
increased megakaryocyte cell number J:85344
premature death J:85344
Mybtm1Jof/Mybtm1Ssp
involves: 129/Sv * C57BL/6 		abnormal definitive hematopoiesis J:85344
abnormal erythropoiesis J:85344
abnormal liver development J:85344
abnormal myeloblast morphology/development J:85344
abnormal T cell differentiation J:85344
decreased thymocyte number J:85344
increased megakaryocyte cell number J:85344
lethality throughout fetal growth and development, complete penetrance J:85344
Mybtm1Ssp/Mybtm1Ssp
either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1) 		abnormal erythropoiesis J:43747
abnormal liver sinusoid morphology J:43747
anemia J:43747
decreased common myeloid progenitor cell number J:43747
decreased erythroid progenitor cell number J:43747
decreased hematocrit J:43747
decreased hematopoietic stem cell number J:43747
increased nucleated erythrocyte cell number J:43747
lethality throughout fetal growth and development, complete penetrance J:43747
pallor J:43747
small liver J:43747
Mybtm1Ssp/Mybtm1Ssp
involves: 129S2/SvPas 		abnormal angiogenesis J:63424
abnormal definitive hematopoiesis J:63424
abnormal erythropoiesis J:63424
abnormal hematopoietic stem cell morphology J:63424
Mybtm2.2Epr/Mybtm2.2Epr
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 		normal hematopoietic system phenotype J:160189
normal immune system phenotype J:160189
normal mortality/aging J:160189
Tg(CD2-Myb/en)2Kmw/?
involves: C57BL/10 * CBA 		abnormal single-positive T cell number J:126456
decreased T cell number J:126456
decreased T cell proliferation J:126456
increased double-negative T cell number J:126456
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
involves: C57BL/10 * CBA 		decreased body size J:126456
decreased double-positive T cell number J:126456
decreased T cell number J:126456
decreased T cell proliferation J:126456
increased double-negative T cell number J:126456
premature death J:126456
small spleen J:126456
small thymus J:126456
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/17/2024
MGI 6.24 		The Jackson Laboratory